Barry Ticho is CHIEF MEDICAL OFFICER of Stoke Therapeutics, Inc.. Currently has a direct ownership of 2,485 shares of STOK, which is worth approximately $32,975. The most recent transaction as insider was on Nov 01, 2024, when has been sold 10,000 shares (Common Stock) at a price of $12.68 per share, resulting in proceeds of $126,800. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.49K
0% 3M change
90.4% 12M change
Total Value Held $32,975

Barry Ticho Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 01 2024
SELL
Open market or private sale
$126,800 $12.68 p/Share
10,000 Reduced 80.1%
2,485 Common Stock
Nov 01 2024
BUY
Exercise of conversion of derivative security
$6,000 $0.6 p/Share
10,000 Added 44.47%
12,485 Common Stock
Oct 01 2024
SELL
Open market or private sale
$120,600 $12.06 p/Share
10,000 Reduced 80.1%
2,485 Common Stock
Oct 01 2024
BUY
Exercise of conversion of derivative security
$6,000 $0.6 p/Share
10,000 Added 44.47%
12,485 Common Stock
Sep 03 2024
SELL
Open market or private sale
$151,700 $15.17 p/Share
10,000 Reduced 80.1%
2,485 Common Stock
Sep 03 2024
BUY
Exercise of conversion of derivative security
$6,000 $0.6 p/Share
10,000 Added 44.47%
12,485 Common Stock
Aug 01 2024
SELL
Open market or private sale
$145,800 $14.58 p/Share
10,000 Reduced 80.1%
2,485 Common Stock
Aug 01 2024
BUY
Exercise of conversion of derivative security
$6,000 $0.6 p/Share
10,000 Added 44.47%
12,485 Common Stock
Jul 01 2024
SELL
Open market or private sale
$137,500 $13.75 p/Share
10,000 Reduced 80.1%
2,485 Common Stock
Jul 01 2024
BUY
Exercise of conversion of derivative security
$6,000 $0.6 p/Share
10,000 Added 44.47%
12,485 Common Stock
Jun 03 2024
SELL
Open market or private sale
$155,000 $15.5 p/Share
10,000 Reduced 80.1%
2,485 Common Stock
Jun 03 2024
BUY
Exercise of conversion of derivative security
$6,000 $0.6 p/Share
10,000 Added 44.47%
12,485 Common Stock
May 01 2024
SELL
Open market or private sale
$113,699 $11.37 p/Share
10,000 Reduced 80.1%
2,485 Common Stock
May 01 2024
BUY
Exercise of conversion of derivative security
$6,000 $0.6 p/Share
10,000 Added 44.47%
12,485 Common Stock
Apr 01 2024
SELL
Open market or private sale
$124,705 $13.23 p/Share
9,426 Reduced 79.14%
2,485 Common Stock
Apr 01 2024
BUY
Exercise of conversion of derivative security
$265 $0.6 p/Share
442 Added 3.58%
11,911 Common Stock
Mar 19 2024
SELL
Open market or private sale
$25,107 $6.1 p/Share
4,116 Reduced 26.41%
11,469 Common Stock
Mar 15 2024
BUY
Exercise of conversion of derivative security
-
13,100 Added 45.67%
15,585 Common Stock
Mar 01 2024
SELL
Open market or private sale
$77,500 $7.75 p/Share
10,000 Reduced 80.1%
2,485 Common Stock
Mar 01 2024
BUY
Exercise of conversion of derivative security
$3,302 $0.6 p/Share
5,504 Added 30.6%
12,485 Common Stock
Feb 01 2024
SELL
Open market or private sale
$48,000 $4.8 p/Share
10,000 Reduced 58.89%
6,981 Common Stock
Jan 02 2024
SELL
Open market or private sale
$57,400 $5.74 p/Share
10,000 Reduced 37.06%
16,981 Common Stock
Jul 03 2023
SELL
Open market or private sale
$159,000 $10.6 p/Share
15,000 Reduced 36.68%
25,895 Common Stock
Jun 01 2023
SELL
Open market or private sale
$166,950 $11.13 p/Share
15,000 Reduced 26.84%
40,895 Common Stock
May 04 2023
SELL
Open market or private sale
$6,530 $10.0 p/Share
653 Reduced 1.15%
55,895 Common Stock
BT

Barry Ticho

CHIEF MEDICAL OFFICER
Bedford, MA

Track Institutional and Insider Activities on STOK

Follow Stoke Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells STOK shares.

Notify only if

Insider Trading

Get notified when an Stoke Therapeutics, Inc. insider buys or sells STOK shares.

Notify only if

News

Receive news related to Stoke Therapeutics, Inc.

Track Activities on STOK